Pfizer Q4 Results 2025 Declared 85% Rise in Profit and 8.3% Surge in Revenue: Check Key Highlights

May 21, 2025
Posted by: sachet
Category: News

Pfizer has reported its Q4 results for FY25 with a robust surge in profit by 85% YoY. Following the rise in profitability. Pfizer India share price surged 10% yesterday on 20th May 2025. Investors are cautious about next trigger of Pfizer India share price and market reactions to its Q4 results for FY25.

Table of Contents

Pfizer India Q4 Results 2025: Key Highlights

Pfizer India reported its revenue surge by 8.3% YoY to reach ₹591.90 crore in the Q4FY25.
Pfizer declares a strong growth of 85% YoY in the net profit, reaching ₹331 crore against ₹179 crore.
EBITDA of Pfizer India is estimated at ₹227.50 crore with a 20.10% YoY increase from the previous EBITDA.
The EBITDA margin of Pfizer India improved to 38.40% from 34.70% in the Q4FY24.

Pfizer India Share Dividend Declaration

The board of directors at Pfizer India has recommended a total dividend of ₹165 per share for the FY25. This dividend amount includes a final dividend of ₹35 per share and a special dividend of ₹100 per share to commemorate the company’s 75th year in India. Moreover, additional ₹30 per share arising from gains on the transfer of leasehold land and building. The record date for Pfizer India dividend is prescribed as 9th July 2025.

Pfizer India Share Performance

Pfizer India share price is currently trading at ₹4,899.60 per share, tumbling over 1.01% or ₹49.80 on 21st May 2025. The stock has delivered 17.26% returns in the past 5 years and 0.71% of Dividend Yield last year. The 52-week high/low of Pfizer India shares is ₹6,451.15/₹3,701.00.

Final Thoughts

Pfizer India declared an 8.3% revenue surge and an 85% profit rise YoY in its Q4 2025 results. The company’s board of directors has recommended a total dividend of ₹165 per share for the FY25. This dividend amount includes a final dividend of ₹35 per share and a special dividend of ₹100 per share to commemorate the company’s 75th year in India. Investors have high confidence in Pfizer India shares for the long term and are waiting for new positive triggers in the shares.

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.